Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Net Long-Term Debt Issued (Repaid) (2021)

Updated

Context Therapeutics' Non-Current Debt was $69,040 in Q4 2020.

Analysis

Context Therapeutics (CNTX) Net Long-Term Debt Issued (Repaid) (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 805,000.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -1.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 9.98 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -19.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 5.87 Mn
API Access

Context Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CNTX&period=max&api_key=YOUR_API_KEY